Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2012-03, Vol.23 (3), p.805-807
Hauptverfasser:	Zinzani, P.L., Derenzini, E., Pellegrini, C., Rigacci, L., Fabbri, A., Gandolfi, L., Argnani, L., Casadei, B., Pulsoni, A., Gobbi, M., Perotti, A., Zaccaria, A., Voso, M.T., Cabras, M.G., De Renzo, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Disease-Free Survival Humans Lymphoma, Follicular - drug therapy Lymphoma, Follicular - mortality Lymphoma, Follicular - radiotherapy Mitoxantrone - administration & dosage Mitoxantrone - adverse effects Radioimmunotherapy - methods Vidarabine - administration & dosage Vidarabine - adverse effects Vidarabine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!